GSK

We are a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. 

We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive.

We prevent and treat disease with specialty medicines, vaccines and general medicines. We focus on the science of the immune system and advanced technologies, investing in four core therapeutic areas - respiratory, immunology and inflammation; oncology; HIV and infectious diseases – to impact health at scale. Our Ahead Together strategy means intervening early to prevent and change the course of disease, helping to protect people and support healthcare systems.

Being a responsible business is an integral part of our strategy and culture. Our Trust priority supports our business performance and long-term growth. It helps us build trust, deliver returns to our shareholders, reduce risk, help people to thrive and deliver sustainable health impact at scale. Six focus areas address what is most material to our business and most important to our stakeholders: access to healthcare, global health and health security, environment, inclusion, ethical standards, product governance.